Skip to main content
Log in

Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

During the pre-symptomatic stage of Parkinson’s disease (PD), the idiopathic PD related abnormal synuclein immunostaining is confined to the medulla oblongata and olfactory bulb, according to Braak. In the study of the enteric nervous system of PD, it has reported that Lewy bodies were found in the Auerbach’s and Meissner’s plexuses. These lesions may cause dysfunction of the gastrointestinal tract (GI) as pre-clinical symptoms of PD. However, because l-dopa therapy itself may worsen the symptoms of the digestive tract function, it is needed to evaluate the gastrointestinal tract function in patients with early-stage, untreated (de novo) PD. In the present study, using the 13C-acetate breath test (13C-ABT), we investigated gastric emptying in 20 untreated, early-stage PD patients and 40 treated, advanced-stage PD patients, and 20 healthy volunteers. Gastric emptying was examined by the 13C-ABT [the half emptying time (HET), the peak time of the 13C% dose-excess curve (T max)]. The T max and HET of gastric emptying as assessed using the 13C-ABT was significantly delayed in untreated, early-stage PD patients as compared to the controls (P < 0.001). The T max and HET of gastric emptying were not significantly delayed in untreated, early-stage PD patients as compared to treated, advanced-stage PD patients. The results demonstrated that delay in gastric emptying did not differ between untreated, early-stage and treated, advanced-stage PD patients. Gastric emptying of untreated, early-stage PD is already delayed. Delayed gastric emptying may be one of markers of the pre-clinical stage of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Djaldetti R, Baron J, Ziv I, Melamed E (1996) Gastric emptying in Parkinson’s disease: patients with and without response fluctuation. Neurology 46:1051–1054

    PubMed  CAS  Google Scholar 

  2. Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, Honigman S, Giladi N (2001) Gastric emptying time and gastric motility in patients with Parkinson’s disease. Mov Disord 16:1041–1047

    Article  PubMed  CAS  Google Scholar 

  3. Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW (1997) Effects of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson’s disease. Mov Disord 12:952–957

    Article  PubMed  CAS  Google Scholar 

  4. Djaldetti R, Koren M, Ziv I, Achiron A, Melamed E (1995) Effect of cisapride on response fluctuations in Parkinson’s disease. Mov Disord 10:81–84

    Article  PubMed  CAS  Google Scholar 

  5. Tanaka Y, Kato T, Nishida H, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T (2009) Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. J Neurol 256:1972–1976

    Article  CAS  Google Scholar 

  6. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–III/5

    Google Scholar 

  7. Jost WH (2009) Gastrointestinal dysfunction in Parkinson’s disease. J Neurol Sci 289:69–73

    Article  PubMed  Google Scholar 

  8. Bramble MG, Cunliffe J, Dellipiani AW (1978) Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson’s disease. J Neurol Neurosurg Psychiatry 41:709–712

    Article  PubMed  CAS  Google Scholar 

  9. Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I (1988) Duodenal and gastric delivery of levodopa in parkinsonism. Ann Neurol 23:589–595

    Article  PubMed  CAS  Google Scholar 

  10. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G (1993) Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104:1640–1647

    PubMed  CAS  Google Scholar 

  11. Braden B, Adams S, Duan LP, Orth KH, Maul FD, Lembcke B, Hör G, Caspary WF (1995) The 13C-acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 108:1048–1055

    Article  PubMed  CAS  Google Scholar 

  12. Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, Schmidt WE, Woitalla D (2006) Predictors of gastric emptying in Parkinson’s disease. Neurogastroenterol Motil 18:369–375

    Article  PubMed  CAS  Google Scholar 

  13. Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752

    Article  PubMed  CAS  Google Scholar 

  14. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  PubMed  CAS  Google Scholar 

  15. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol II. Macmillan Healthcare Information, Florham Park, pp 153–163, 293–304

  16. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

    PubMed  CAS  Google Scholar 

  17. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G (1998) Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93:1090–1096

    Article  PubMed  CAS  Google Scholar 

  18. Medow MS, Stewart JM, Sanyal S, Mumtaz A, Sica D, Frishman WH (2008) Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 16:4–20

    Article  PubMed  Google Scholar 

  19. Kuroiwa Y, Wada T, Tohgi H (1987) Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol 235:65–68

    Article  PubMed  CAS  Google Scholar 

  20. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:189–194

    Article  PubMed  CAS  Google Scholar 

  21. Gatti C, di Abriola FF, Dall’Oglio L, Villa M, Franchini F, Amarri S (2000) Is the 13C-acetate breath test a valid procedure to analyse gastric emptying in children? J Pediatr Surg 35:62–65

    Article  PubMed  CAS  Google Scholar 

  22. Gonza´lez A, Mugueta C, Parra D, Labayen I, Martinez A, Varo N, Monreal I, Gil MJ (2000) Characterisation with stable isotopes of the presence of a lag phase in the gastric emptying of liquids. Eur J Nutr 39:224–228

    Article  Google Scholar 

  23. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76:217–221

    Article  PubMed  CAS  Google Scholar 

  24. Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72

    Article  PubMed  CAS  Google Scholar 

  25. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253–1255

    PubMed  CAS  Google Scholar 

  26. Calne DB, Brennan J, Spiers AS, Stern GM (1970) Hypotension caused by l-dopa. Br Med J 1:474–475

    Article  PubMed  CAS  Google Scholar 

  27. Caplan LH, Jacobson HG, Rubinstein BM, Rotman MZ (1965) Megacolon and volvulus in Parkinson’s disease. Radiology 85:73–78

    PubMed  CAS  Google Scholar 

  28. Edwards LL, Pfeiffer RF, Quigley EMM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156

    Article  PubMed  CAS  Google Scholar 

  29. Klaue R (1940) Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus. Archiv für Psychiatrie 111:251–321

    Article  Google Scholar 

  30. Kuroiwa Y, Shimada Y, Toyokura Y (1983) Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 33:463–467

    PubMed  CAS  Google Scholar 

  31. Parkinson J (1817) An essay on the shaking palsy. Sherwood, Neely, and Jones, London, pp 1–66

    Google Scholar 

  32. Turkka JT, Juujärvi KK, Lapinlampi TO, Myllylä VV (1986) Serum noradrenaline response to standing up in patients with Parkinson’s disease. Eur Neurol 25:355–361

    Article  PubMed  CAS  Google Scholar 

  33. Korczyn AD (1990) Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol 53:463–468

    PubMed  CAS  Google Scholar 

  34. Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M, Yoshiyama M, Hattori T (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci 92:76–85

    Article  PubMed  CAS  Google Scholar 

  35. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the risk of Parkinson’s disease. Neurology 57:456–462

    PubMed  CAS  Google Scholar 

  36. Wolters ECh, Braak H (2006) Parkinson’s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309–319

    Article  PubMed  Google Scholar 

  37. Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal system: implications for Parkinson’s disease. Mov Disord 23:1065–1075

    Article  PubMed  Google Scholar 

  38. Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology 42:726–732

    PubMed  CAS  Google Scholar 

  39. Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10:249–258

    Article  PubMed  CAS  Google Scholar 

  40. Lanfranchi GA, Marzio L, Cortini C (1977) Effect of dopamine in gastric motility in man: evidence for specific receptors. In: Duthie HL (ed) Gastrointestinal motility in health and disease. MTP Publishers, Lancaster, pp 161–172

    Google Scholar 

  41. Urbain JL, Charkes ND (1995) Recent advances in gastric emptying scintigraphy. Semin Nucl Med 25:318–325

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

All authors report no disclosure.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuji Tanaka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, Y., Kato, T., Nishida, H. et al. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson’s disease? An analysis using the 13C-acetate breath test. J Neurol 258, 421–426 (2011). https://doi.org/10.1007/s00415-010-5769-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5769-z

Keywords

Navigation